Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

We compared serious early and late events experienced by 2726 bone marrow (BM) and 6768 peripheral blood stem cell (PBSC) donors who underwent collection of PBSC or BM between 2004 and 2009 as part of a prospective study through the National Marrow Donor Program. Standardized FDA definitions for ser...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pulsipher, Michael A., Chitphakdithai, Pintip, Logan, Brent R., Navarro, Willis H., Levine, John E., Miller, John P., Shaw, Bronwen E., O’Donnell, Paul V., Majhail, Navneet S., Confer, Dennis L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2014
Assuntos:
Transfusion Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4047500/
https://ncbi.nlm.nih.gov/pubmed/24735965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-12-542464
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados